4basebio UK Societas (LON:4BB) and Circassia Group (LON:CIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership.
Earnings and Valuation
This table compares 4basebio UK Societas and Circassia Group's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
4basebio UK Societas | N/A | N/A | N/A | N/A | N/A |
Circassia Group | £23.90 million | 5.07 | N/A | GBX (8.80) | -3.30 |
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for 4basebio UK Societas and Circassia Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
4basebio UK Societas | 0 | 0 | 0 | 0 | N/A |
Circassia Group | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares 4basebio UK Societas and Circassia Group's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
4basebio UK Societas | N/A | N/A | N/A |
Circassia Group | N/A | N/A | N/A |
Summary
Circassia Group beats 4basebio UK Societas on 1 of the 1 factors compared between the two stocks.